» Authors » Shoko Nozaki

Shoko Nozaki

Explore the profile of Shoko Nozaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Koreki A, Nozaki S, Shikimoto R, Tsugane S, Mimura M, Sawada N
J Alzheimers Dis . 2025 Jan; 103(2):519-527. PMID: 39772974
Background: While the preventive effects of green tea and coffee on cognitive decline have been demonstrated, their long-term effects on cognition remain unclear. Objective: This study aims to investigate the...
2.
Shikimoto R, Nozaki S, Sawada N, Shimizu Y, Svensson T, Nakagawa A, et al.
J Alzheimers Dis . 2022 Oct; 90(3):1085-1101. PMID: 36213991
Background: The relationship between coping in mid- to late life and cognitive functions remains unclear. Objective: To investigate the relationship between habitual coping behaviors of a large Japanese population in...
3.
Narita Z, Nozaki S, Shikimoto R, Hori H, Kim Y, Mimura M, et al.
Transl Psychiatry . 2022 Sep; 12(1):412. PMID: 36163244
We evaluated the association between vegetable and fruit consumption - particularly flavonoid-rich fruits - in mid-life and major depressive disorder (MDD) in later life. We also evaluated the association of...
4.
Mashima Y, Koizumi T, Minegishi S, Miyakoshi M, Okada M, Ogyu K, et al.
Int J Soc Psychiatry . 2022 Jun; 68(5):969-980. PMID: 35652327
Background: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a total upending of our daily lives. While anxiety and depression were frequently reported among the general population, the pandemic's...
5.
Ogawa K, Shirai K, Nozaki S, Shikimoto R, Sawada N, Mimura M, et al.
Transl Psychiatry . 2022 Apr; 12(1):156. PMID: 35410408
This study investigates the longitudinal association between living arrangements and psychiatrists' diagnosis of depression in the general population. In 1990, 1254 Japanese men and women aged 40-59 years were enroled...
6.
Svensson T, Sawada N, Mimura M, Nozaki S, Shikimoto R, Tsugane S
J Epidemiol . 2021 Dec; 33(7):342-349. PMID: 34924453
Background: The number of people with cognitive impairment, including dementia, in the world is steadily increasing. Although the consumption of isoflavones and soy is associated with a reduced risk of...
7.
Koreki A, Kusudo K, Suzuki H, Nozaki S, Onaya M, Bowes A, et al.
Dement Geriatr Cogn Dis Extra . 2021 Oct; 11(3):207-212. PMID: 34703454
Background: In ageing population, it is desirable to reduce the impact of cognitive decline on daily life. While various types of dementia-friendly environments have been proposed, the question still remains...
8.
Koreki A, Mori H, Nozaki S, Koizumi T, Suzuki H, Onaya M
J Clin Psychopharmacol . 2021 Jun; 41(4):474-477. PMID: 34086626
Background: Although the prevalence of metabolic syndrome in patients with schizophrenia is higher than the prevalence in the general population, little is known regarding nonalcoholic fatty liver disease (NAFLD) in...
9.
Hamazaki K, Matsuoka Y, Yamaji T, Sawada N, Mimura M, Nozaki S, et al.
Sci Rep . 2021 Feb; 11(1):4003. PMID: 33597590
The beneficial effects of n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on depression are not definitively known. In a previous population-based prospective cohort...
10.
Nozaki S, Sawada N, Matsuoka Y, Shikimoto R, Mimura M, Tsugane S
J Alzheimers Dis . 2021 Jan; 79(3):1091-1104. PMID: 33386799
Background: The relationship between midlife dietary habits and risk of dementia remains unclear. Objective: To investigate the association between dietary fish and n-3 polyunsaturated fatty acid (PUFA) consumption in midlife...